UTHR
NASDAQ · Biotechnology
United Therapeutics Corp
$531.82
+10.60 (+2.03%)
Performance
1D
—
1W
—
1M
—
3M
+4.86%
6M
+22.92%
1Y
+67.91%
YTD
+7.07%
Open$520.14
Previous Close$521.22
Day High$536.02
Day Low$517.59
52W High$519.99
52W Low$266.98
Volume—
Avg Volume270.7K
Market Cap20.54B
P/E Ratio16.15
EPS$26.41
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$485.49
Above
SMA 200
$394.55
Above
RSI (14)
60.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
21 analysts
Price Target
-83.4% upside
Current
$531.82
$531.82
Target
$88.53
$88.53
$65.70
$88.53 avg
$121.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.56B | 2.15B | 2.73B |
| Net Income | 1.07B | 802.14M | 406.29M |
| Profit Margin | 41.5% | 39.5% | 14.9% |
| EBITDA | 1.31B | 1.04B | 733.08M |
| Free Cash Flow | — | — | 513.48M |
| Rev Growth | +19.5% | +19.5% | +4.0% |
| Debt/Equity | 0.05 | 0.05 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |